Nelarabine
Arranon, Atriance (nelarabine) is a small molecule pharmaceutical. Nelarabine was first approved as Arranon on 2005-10-28. It is used to treat t-cell leukemia in the USA. It has been approved in Europe to treat precursor t-cell lymphoblastic leukemia-lymphoma.
Trade Name | Atriance |
---|---|
Common Name | Nelarabine |
Indication | precursor t-cell lymphoblastic leukemia-lymphoma, t-cell leukemia |
Drug Class | Antineoplastics (arabinofuranosyl derivatives) |